Skip to content
The Kids Research Institute Australia logo
Donate

Search

Research

Efficacy of the MiniMed™ 670G hybrid closed loop system in managing postprandial glucose excursion with high protein high fat foods in children and adolescents under free-living conditions

High protein high fat meals are considered “difficult” foods because they can cause prolonged hyperglycemia after ingestion. The potential of hybrid closed loop therapy in managing postprandial glucose excursions with these difficult foods remains unknown. This pilot study aimed to explore the impact of manual mode in standard insulin pump therapy and auto mode with hybrid closed loop pump therapy in managing glucose excursions caused by HPHF foods and to obtain feedback from families about each mode.

Research

Contribution of an intrinsic lag of continuous glucose monitoring systems

Current continuous glucose monitoring (CGM) systems measure glucose levels in the interstitial fluid to estimate blood glucose concentration.

Research

Type 2 Diabetes in Indigenous Australian children

Rates of type 2 diabetes are higher among Indigenous than non-Indigenous Australian children and adolescents.

Research

Exercise alone reduces insulin resistance in obese children independently of changes in body composition

The number of obese children with insulin resistance and type 2 diabetes is increasing, but the best management strategy is not clear.

Research

Diabetes, Metabolism and Clinical Sciences

Listed are all The Kids Research Institute Australia research teams involved in our Diabetes and Obesity Program. This program sits under the Chronic and Severe Diseases research theme.

Research

Type 1 and Type 2 Diabetes DNA bank

A register which stores demographic and clinical data on all patients attending the diabetes clinic at Princess Margaret Hospital

Research

The effect of oral insulin on subcutaneous insulin requirements and glycaemia in T1DM

Liz Tim Davis Jones MBBS FRACP PhD MBBS DCH FRACP MD Theme Head, Chronic & Severe Diseases; Clinical Lead, Diabetes and Obesity Research Co-head,

News & Events

What life is like living with type 1 diabetes

Every decision a child with type 1 diabetes makes can impact on their blood glucose levels.

Research

Clinical Outcomes with MiniMedTM 780G Advanced Hybrid Closed-Loop Therapy in 2- to 6-Year-Old Children with Type 1 Diabetes

Advanced hybrid closed-loop (AHCL) therapy with the Medtronic MiniMed™ 780G system improves glycemia; however, the clinical outcomes in younger children remain less established. This pilot study aimed to explore the continuous glucose monitoring (CGM) metrics in very young children on AHCL. Children between 2 and 7 years of age and on insulin pump therapy were recruited.